Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2025-12-26 @ 10:59 PM
Study NCT ID:
NCT00689403
Status:
COMPLETED
Last Update Posted:
2010-12-03
First Post:
2008-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D3190C00014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Helen Lunde, MD, Medical Science Director, Emerging Arrhythmia and Lipids
Old Organization:
AstraZeneca